One size does not fit all: evaluating an intervention to reduce antibiotic prescribing for acute bronchitis

Sara L Ackerman1, Ralph Gonzales, Melissa S Stahl

  • 1Department of Social and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA. sara.ackerman@ucsf.edu.

Abstract

Insights

Reducing antibiotic prescribing for respiratory infections remains challenging. Clinicians face barriers like patient expectations and diagnostic uncertainty, hindering intervention effectiveness.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Primary Care Medicine

Background:

  • Antibiotic overuse for viral upper respiratory tract infections (URIs) and acute bronchitis is a significant problem in the U.S.
  • Over 50% of patients with URIs and acute bronchitis receive antibiotics annually, despite most cases being viral.
  • Previous interventions to curb unnecessary antibiotic prescribing have shown limited success.

Purpose of the Study:

  • To understand why a multi-level intervention to reduce antibiotic prescribing for acute bronchitis only improved prescribing in one-third of clinicians.
  • To explore primary care provider perspectives on antibiotic prescribing and intervention strategies.

Main Methods:

  • A mixed-methods approach was used, combining surveys and intervention evaluation.
  • Structured telephone surveys were conducted with 29 clinicians at high and low-performing sites after one year of intervention.
  • Clinician perspectives on print-based, electronic, and general antibiotic prescribing strategies were elicited.

Main Results:

  • Clinicians showed increased awareness of antibiotic resistance and their role in it compared to a decade prior.
  • Persistent barriers to reducing antibiotic prescribing included patient expectations, time constraints, and diagnostic uncertainty.
  • An in-exam room poster with a diagnostic algorithm was the most favored intervention component.

Conclusions:

  • Future interventions must address multi-level barriers identified by clinicians, such as patient-provider decision-making dynamics.
  • Strategies should be tailored to individual clinician and group practice needs to effectively reduce antibiotic prescribing.
  • Focusing on shared decision-making can improve antibiotic stewardship for acute respiratory conditions.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
406
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605